Gennex Laboratories share news, announcements and annual reports
BSE: 531739Pharmaceuticals & BiotechnologySmall Cap
Gennex Laboratories Ltd · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1996
Last close ₹8.02down ₹0.94 (10.49%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹8.96.
30 Oct: open ₹8.91, high ₹9.12, low ₹7.70
52-week range of traded prices to 30 Oct 2026
₹7.05Low, 30 Mar 2026₹16.99High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹195 Cr2,248th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 10.60
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 13,21,688
Gennex Laboratories shareholder meetings
52 filed, newest first. Page 1 of 2.
Oct 2026
Sep 2026
May 2026
Apr 2026
Oct 2025
Sep 2025
Oct 2024
Sep 2024
Dec 2023
Oct 2023
Sep 2023
Oct 2022
Sep 2022
Oct 2021
Sep 2021
Sep 2020
Sep 2019
6 Sep · Meeting
Aug 2019
Aug 2018
Oct 2017
Sep 2017
Aug 2017
Sep 2016
2 Sep · Meeting
Aug 2016
Sep 2015
Aug 2015
25 Aug · Meeting
Oct 2014
6 Oct · Meeting
Sep 2014
Sep 2013
Oct 2012
Oct 2011
1 Oct · Meeting
Members at the 26th Annual General Meeting (AGM) of the Company held on September 30, 2011, inter alia, have accorded to the following: ....
Sep 2011
21 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 27, 2011 to September 30, 2011 (both days inclusive) ....
Oct 2010
4 Oct · Meeting
Members at the 25th Annual General Meeting (AGM) of the Company held on September 30, 2010, inter alia, have accorded to the following: ....